Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Meridian Bioscience's Average Total Inventories for the quarter that ended in Sep. 2022 was $69.0 Mil. Meridian Bioscience's Revenue for the
three
months ended in Sep. 2022 was $65.7 Mil.
Meridian Bioscience's Inventory-to-Revenue for the quarter that ended in Sep. 2022 was 1.05.
Meridian Bioscience's Inventory-to-Revenue for the quarter that ended in Sep. 2022
increased
from Jun. 2022 (1.04) to Jun. 2022 (1.05)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Meridian Bioscience's Days Inventory for the
three
months ended in Sep. 2022 was 198.61.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Meridian Bioscience's Inventory Turnover for the quarter that ended in Sep. 2022 was 0.46.
Meridian Bioscience Inventory-to-Revenue Historical Data
The historical data trend for Meridian Bioscience's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Meridian Bioscience's Inventory-to-Revenue
For the Diagnostics & Research subindustry, Meridian Bioscience's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meridian Bioscience's Inventory-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Meridian Bioscience's Inventory-to-Revenue falls into.
Meridian Bioscience Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Meridian Bioscience's Inventory-to-Revenue for the fiscal year that ended in Sep. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meridian Bioscience (NAS:VIVO) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Meridian Bioscience's Days Inventory for the
three
months ended in Sep. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meridian Bioscience Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Meridian Bioscience's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Meridian Bioscience (Meridian Bioscience) Business Description
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIVO has been successfully added to your 